Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Selective .beta..sub.3 adrenergic agonists

Selective .beta..sub.3 adrenergic agonists

US Patent 6075040 · Granted Jun 13, 2000

Estimated economic value: $150,326,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

[1,2,4]Triazolo derivatives as PDE1 inhibitors for the treatment of diabetes2022
Azetidinyloxyphenylpyrrolidine compounds2020
PDE1 inhibitor2018
Aldosterone synthase inhibitor2014
4-aminobenzonitrile selective androgen receptor modulators2014
Histamine H3 receptor agents, preparation and therapeutic uses2012
Compounds and methods for modulating FXR2012
Histamine H3 receptor agents, preparation and therapeutic uses2011
Histamine H3 receptor agents, preparation and therapeutic uses2011
Tetrahydrocyclopenta[b]indole compounds as androgen receptor modulators2011
Pyrrolidine derivatives as histamine H3 receptor antagonists2011
Tetrahydrocarbazole derivatives useful as androgen receptor modulators2011